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ABSTRACT
Nutraceuticals, functional food ingredients and dietary supplements are important for health promotion and disease risk
reduction. Although a myriad of bioactives are known to render the expected beneficial effects, the mechanisms involved are
varied and may work individually or collectively in providing the effects. For example, phenolic compounds are known to act as
antioxidants or by mechanisms that are independent of their antioxidant activity. In addition, conjugation of bioactives with other
active or inactive components may affect the activity of the resultant products. Therefore, conjugation of phytosterols with
docosahexaenoic acid (DHA) was found to lower cholesterol in a mouse model and esters of epigallocatechin gallate with
docosahexaenoic acid were able to arrest colon cancer in mice. Processing of bioactives may also alter their bioactives and could
therefore influence their efficacy in in-vitro and possibly in vivo models. In addition, processing by-products from plant sources
are particularly rich in a number of bioactives at much higher concentration than those present in the main products and these can
be used as value-added ingredients for application in food or as supplements for alleviating certain health problems. Examples
will be provided to illustrate the concepts and approaches used and expected benefits.
Key words: nutraceuticals, functional foods, dietary supplements, phenolic compounds and their modification, omega-3
polyunsaturated fatty acids, phytosterols, green tea epigallocatechins gallate, plant by-product, health effects

INTRODUCTION
Functional foods are defined as products that resemble traditional foods but possess demonstrated physiological benefits. However, nutraceuticals are commodities
derived from foods, but are used in the medicinal form of
pills, capsules or liquids and again render demonstrated
physiological benefits. In Canada, the latter group has
now been integrated under a new category as natural
health products that promote health. This category includes both nutraceuticals and herbal as well as other
natural products. In some countries, however, functional
foods and nutraceuticals are used interchangeably. Regardless, the main focus of such products is to improve
health and reduce disease risk through prevention. The
main difference of this category with pharmaceuticals is
that they are multi-targeted mixtures and present at low
concentration while pharmaceuticals are uni-targeted pure
compounds with high dose use.
There are many functional foods and nutraceuticals
that are becoming increasingly available in the
marketplace, but there is a challenge for the functional
food producers because such products should address the
issue of sensory acceptability which is not necessary for
the nutraceutical or pharmaceutical products. The
commodities that have so far reached the market are

mainly those belonging to the antioxidants and also
omega-3 oils, as well as probiotics, among others. The
antioxidant category is primarily composed of
phenolic/polyphenolic compounds, but carotenoids as
well as phytates, certain vitamins, uric acid and minerals
are also included. In addition, phytosterols or plant sterols
have found their way to the market, first in Finland over a
decade ago and now in many other countries. In more
recent work, conjugation of different groups of bioactives
or their physical mixtures have been studied in order to
examine their additive or possible synergistic as well as
unusual effects. The following sections of this overview
provide examples to demonstrate the benefits of
nutraceuticals and functional foods in health promotion
and in reducing the risk of chronic diseases.

PHENOLICS AND POLYPHENOLICS AS
ANTIOXIDANTS
Plant foods serve as a rich source of phenolic and
polyphenolic compounds. The concentration of phenolics
and polyphenolics is mainly in the skin and seeds of
fruits, but leaves often provide a richer source of
phenolics. An example for this is blueberry leaves that are
excellent sources of antioxidants (1) . The leaves were
more recently found to suppress the expression of
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hepatitis C virus RNA(2). In cereals and legumes, the bran
portion is also dominant in phenolics as compared to the
endosperm(3). The antioxidant potential of cereals follows
a similar trend as is exemplified in pearled barley.
Although the term antioxidant is frequently used by the
public to describe the health benefits of phenolic and
polyphenolic compounds, the mechanism(s) by which
these effects are rendered is (are) not limited to their
antioxidant potential which may be described as their
efficacy in scavenging free radicals, chelating pro-oxidant
metal ions or acting as reducing agents. Table 1
summarizes the different mechanisms by which phenolic
and polyphenolic antioxidants confer their benefits, once
consumed. It should also be noted that certain flavonoids
may exert their beneficial effects via a pro-oxidant
effect(4). In addition, advanced glycation endpoints
(AGEs) responsible for diabetes, cataract, neuropathy and
alike are among the other mechanisms by which
phenolics/polyphenolics are known to promote health(5).
The phenolics occurring in foods may occur in the free,
soluble esters and glycosides or insoluble-bound forms.(6)
In carrying out extraction operations, the latter group may
not be easily procured, if proper procedures to release
them are not followed. This may then lead to the
underestimation of the reported results. Thus release of
the insoluble-bound phenolics is essential. The
correspondence of total phenolics with antioxidant
potential as well as the contribution of insoluble-based
phenolics to the total phenolics in several cases has been
summarized in Table 2. These bound phenolics are
released during colonic fermentation and hence are of
paramount importance in reducing the risk of colon
cancer.
Table 1. Mechanisms of action of phenolic and polyphenolic
compounds
․

Direct Removal of ROS/RNS or potentiation of cellular antioxidant capacity

․

Affecting cell differentiation

․

Increasing the activity of carcinogen detoxifying enzymes

․

Blocking the formation of N-nitrosamines

․

Altering the estrogen metabolism and/or colonic milieu
Increasing apoptosis of cancerous cell and/or decreasing cell proliferation
Affecting DNA methylation and/or maintaining DNA
repair

․
․
․

Preserving the integrity of intracellular matrices

․

Other mechanisms

OMEGA-3 OILS AND THEIR HEALTH BENEFITS
Edible marine algae, sometimes referred to as seaweeds, are of interest as good sources of nutrients including protein, long-chain polyunsaturated fatty acids
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(PUFA), dietary fibres, vitamins and minerals. More recently, many researchers have focused on marine algae
and their constituents as nutraceuticals and functional
foods for their potential health-promotion mostly attributed to their ω3 fatty acids, antioxidants, and other bioactives. Although the majority of marine algae have low
lipid contents, ranging from 0.3% in U. lactuca to 7.2%
in Caulerpa lentillifera(7), algal lipids are rich in PUFA
such as C20 : 5ω3 (eicosapentaenoic acid, EPA) and C22 :
6ω3 (docosahexaenoic acid, DHA). The proportions of
EPA and DHA in oils from Skeletonema costatum and
Crypthecodinium cohnii were 41 and 37%, respectively(8).
While marine algae are primarily used for production of single-cell oil rich in DHA, and other ω3 PUFA (9,
10)
, the leftover material after processing contains a variety of antioxidative substances that can potentially be
utilized as a source of natural antioxidants.
The omega-3 oils, although originating from
phytoplanktons or algae, are transferred to marine fish
and mammals through the food web. Lipids from the
body of fatty fish such as mackerel and herring, the liver
of white lean fish such as cod and halibut, and the blubber
Table 2. Total phenolic content of selected cereals or their fractions
and corresponding antioxidant activity
Material

Total Phenolics

Antioxidant Activity

Wheat (Soft, bran)

66.91

55.80

Wheat (Soft, flour)

24.11

27.10

Barley (outermost layer)

6.26

59.70

Barley (Innermost layer)

0.51

0.45

Millet (Kodo, whole
grain-soluble)

32.40

95.70

Millet (Kodo, dehulled
grain- soluble)

6.86

41.00

Millet (Kodo, whole
grain-bound)

81.60

79.30

(41.68)

(86.1)

Total phenolics are recorded as mg ferulic acid equivalents/g crude
extract for wheat and barley and as µmol ferulic acid equivalents/g
defatted meal for millet. Antioxidant Activity is measured as µmol
Trolox eg/g defatted for wheat and barley in TEAC assay and for
millet in ORAC assay. Data are from Liyana-Pathirana and Shahidi(3)
and Madhujith et al., 2006(35) and Chandrasekara and Shahidi(6), or
2011(34)(TEAC value, in parenthesis).

of marine mammals such as seals and whales are rich in
long-chain ω3 fatty acids. The ω3 PUFA include the essential fatty acid α-linolenic acid (C18 : 3 ω3, ALA) and
its long-chain metabolites through elongation and desaturation, EPA, DPA (docosapentaenoic acid, C22 : 5 ω3)
and DHA. ALA is abundant in certain plant sources such
as flaxseed and to a lesser extent perilla, soybean and
canola as well as walnuts(11). EPA and DHA are mainly
derived from marine fish, shellfish and algae, while DPA
is present in significant amounts only in oils from marine
mammals such as seal blubber oil. The distribution pat-
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tern of fatty acids in triacylglycerols (TAG) differs in fish
and marine mammal oils, which greatly influence the
metabolism, deposition and potential health benefits(12).
Long-chain ω3 PUFA are mainly located in the sn-2 position of TAG in fish oils, whereas in marine mammal lipids they are predominantly in the sn-1 and sn-3 positions.
More recently, ω3 oils from by-products of fishery and
fish processing industries have attracted special attention.
By-products from fish processing including heads, frames,
skin and viscera contain considerable amounts of ω3
PUFA-rich oil and utilization of marine by-products as
good sources of ω3 oil is of great interest(13,14).
The omega-3 oils with their important role in health
promotion and prevention/treatment of a number of
chronic diseases may be included in foods such as bakery
products, pastas, dairy products, spreads and juices, and
may also be used as dietary supplements in liquid or capsule forms(11). In the area of food application of ω3 oils or
even as supplement, microencapsulation techniques have
been used to protect the oils from oxidation and
off-flavour development. The microcapsules produced by
a coacervation method are released in the gastrointestinal
tract after consumption, hence no adverse effect is noted
in the products in terms of flavour perception(15).
The use of omega-3 oils/long-chain ω3 PUFA
constitutes one of the most promising developments in
human nutrition and disease risk reduction in the past
three decades. Long-chain ω3 PUFA are of great interest
because of their effectiveness in prevention and treatment
of coronary heart disease(16), hypertension(17), diabetes(18),
arthritis and other inflammations(19), autoimmune
disorders(20) mental health and neural function as in
depression and schizophrenia(11) and cancers(21,22) and are
essential for maintenance and development of normal
growth, especially for the brain and retina(23). There has
been growing evidence showing that regular consumption
of fish oils containing ω3 PUFA can lower the rate of
incidence and death from cardiovascular disease
including ischemic heart disease, nonischemic myocardial
heart disease, and hypertension(11). While the exact
biochemical mechanism for cardioprotective effect of ω3
fatty acids is unknown, hypotheses state that this may be
attributed
collectively
to
their
antiarrhythmic,
antiatherogenic and antithrombotic activities. Long-chain
PUFA can lower serum triacylglyerols(24), increase
membrane fluidity and reduce thrombosis by conversion
to eicosanoids(25). They provide specific physiological
functions against thrombosis, cholesterol build-up and
allergies(26).
Recently, omega-3 concentrates with a total EPA
plus DHA content of 85% as ethyl esters have been used
as prescription drugs for reducing blood pressure and
triacylglycerols. Products have been sold under the brand
name Amacor or Loveza and generic brands are expected
to enter the market in 2012. In addition, Eli Lilly
markets EPA capsules for treatment of Schizophrenia.
This shows that omega-3 oils, not only are used as
nutraceuticals and functional food ingredients, they may
also be taken as pharmaceuticals.
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Table 3. Examples of different forms of omega-3 fatty acid/oil
products
Triacylglycerol (TAG) or TAG concentrate
Ethyl ester (EE) or EE concentrate of eicosapentaenoic acid
(EPA) and/or docosahexaenoic acid (DHA)
Phospholipid
Calcium and magnesium salts
Chromium (III) – DHA complex
Phytosterol-DHA ester
Epigallocatechin gallate (EGCG) – DHA ester

BIOACTIVE CONJUGATES
In efforts to examine the additive, synergistic or unusual effects of conjugates of different bioactives,
Kralovec et al.(27) prepared chromium (III) complex of
DHA in order to take advantage of its constituent components. Later, we prepared, for the first time, conjugates
of major green tea polyphenol or phytosterols with a
number of fatty acids, particularly long-chain omega-3
fatty acids (Table 3).
Polyphenols in green tea, known as catechins, account for 30% of the dry weight of tea leaves with epigallocatechin gallate (EGCG) being the most abundant
(59% of total polyphenols). EGCG has a multitude of
bioactivities and is highly hydrophilic with poor solubility in lipophylic media, hence its absorption in-vivo is
some-what hindered. Acylation of EGCG with selected
fatty acids(28) was found to improve its lipophibicity, thus
leading to its potential expanded application in more diverse systems such as fats and oils, lipid-based foods and
cosmetics as well as biological systems, including better
cellular absorption and bioefficacy under physiological
conditions. Moreover, additional perspectives exists using
health beneficial omega-3 (PUFA). The esters of EGCG
with omega-3 PUFA, especially DHA significantly improved the antioxidant and anti-inflammatory activities of
EGCG. Moreover, the EGCG-DHA esters totally arrested
colon tumourigensis in mice(29) and exhibited anti-HCV
(hepatitis C virus) activity which was 1700-folds greater
than that of embelin as a positive control(30). These
findings strongly suggest that modified EGCG products
are of great potential as novel ingredients for food and
cosmetics and as nutraceutical/pharmaceutical applications. These findings have now been protected through a
patent(31).
The esters of phytosterols with omega-3 fatty acids
as well as a number of phenolic acids have also been prepared. While most of the research and commercial interest has so far been on phytosterol esters with vegetable
oils, this research has successfully used enzymatic or
chemoenzymatic preparation of novel phytosterol esters
with DHA and other long-chain omega-3 fatty acids as
well as for the synthesis of phytosteryl caffeates, ferulates,
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sinapates and vannilate. We have also found that phytosteryl oleates to have cholesterol lowering effects that exceed those with DHA.
The antioxidant potential of phytosteryl phenolates
in a number of in-vitro systems have been shown to be
system-dependent and being influenced by a number of
mechanisms involved in rendering their effects.
Phytosteryl phenolates, especially phytosteryl caffeates,
ferulates and sinapates, provide an excellent opportunity
for their future use as food antioxidants(32). The
cholesterol and triacylglycerol lowering effects of
phytosteryl oleates and docosahexeanates is also of much
interest as the components of latter products may render
combined effects of their constituent moieties. In an
apo-E deficient mice, the cholesterol lowering effects of
products and in nearly removing atherosclerotic lesion
has already been demonstrated(33).
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